Lawsuits from alleged victims of GranuFlo continue to rise.
GranuFlo Lawsuit Claims That Recalled Dialysis Drugs Caused Fatal Complications
October 07, 2014 via prweb.com A Texas widow had filed a GranuFlo lawsuit alleging the death of her husband was caused by Fresenius Medical Care’s recalled dialysis concentrates. According to the complaint, which was transferred to the multidistrict litigation in the U.S. District Court, District of Massachusetts on September 4th, the decedent underwent dialysis treatments with GranuFlo and/or NaturaLyte from 2011 to 2013, which allegedly caused him to suffer metabolic alkalosis and cardiac arrest, ultimately leading to his death. (1:2014cv13562)
GranuFlo and NaturaLyte Recall
Both GranuFlo and NaturaLyte are dialysis concentrates manufactured by Fresenius Medical Care, and both are administered during hemodialysis in order to remove toxins from the blood. In March 2012, Fresenius issued an Urgent Product Notification for both products that warned of dosage issues that could cause dialysis patients to suffer serious and catastrophic heart side effects. The U.S. Food & Drug Administration (FDA) ultimately granted Class I recall status to the Urgent Product Notification, which indicates GranuFlo and NaturaLyte posed a risk of serious injury and death. Court documents indicate that more than 2,000 lawsuits have been filed in the District of Massachusetts on behalf of dialysis patients who allegedly experienced serious cardiovascular events related to the GranuFlo and NaturaLyte recall. All of the claims similarly allege that Fresenius failed to provide adequate warnings regarding the risks associated with GranuFlo and NaturaLyte, and that the company continued to aggressively market the products even once it became aware of those risks. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428) In addition to the cases pending in the District of Massachusetts, additional GranuFlo and NaturaLyte lawsuits have been consolidated on the state level in the Massachusetts’ Middlesex County Superior Court. Filings indicate that more than 3,900 claims are pending in that proceeding. Dialysis patients who were allegedly harmed by GranuFlo or NaturaLyte may be entitled to compensation for medical bills, lost wages, pain and suffering and more. Ball and Bonholtzer is offering free GranuFlo lawsuit evaluations to dialysis patients, their family or loved ones, who allegedly suffered cardiac arrest, heart attacks, stroke, sudden cardiac death or other side effects within 72 hours of a dialysis treatment involving the use of GranuFlo or NaturaLyte dialysis drugs. Please call our office for a free case evaluation at 626-793-2117. Originally posted by prweb. Granuflo Lawsuit 2014 and Naturalyte Lawsuit 2014 – Ball & Bonholtzer